Other

Other investing activities, net

Vertex Pharmaceuticals Other investing activities, net remained flat by 0.0% to $6.18M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 54.3%, from $13.50M to $6.18M. Over 2 years (FY 2023 to FY 2025), Other investing activities, net shows a downward trend with a -10.7% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ3 2025

How to read this metric

Fluctuations usually represent one-time events or minor adjustments in the investment portfolio.

Detailed definition

Net cash flows resulting from miscellaneous investing activities that do not fit into standard categories like capital e...

Peer comparison

Often contains noise; should be reviewed for one-time non-recurring items.

Metric ID: is_jpm_other_investing_activities_net

Historical Data

3 years
 FY'23FY'24FY'25
Value$31.00M$54.00M$24.70M
YoY Change—+74.2%-54.3%
Range$24.70M – $54.00M
CAGR-10.7%
Avg YoY Growth+10.0%
Median YoY Growth+10.0%

Other investing activities, net at Other Companies

GLW
CorningGLWView metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's other investing activities, net?
Vertex Pharmaceuticals (VRTX) reported other investing activities, net of $6.18M in Q4 2025.
How has Vertex Pharmaceuticals's other investing activities, net changed year-over-year?
Vertex Pharmaceuticals's other investing activities, net decreased by 54.3% year-over-year, from $13.50M to $6.18M.
What is the long-term trend for Vertex Pharmaceuticals's other investing activities, net?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's other investing activities, net has grown at a -10.7% compound annual growth rate (CAGR), from $31.00M to $24.70M.
What does other investing activities, net mean?
Net cash from minor or non-standard investing activities.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.